Gender_NN
and_CC
vascular_JJ
reactivity_NN
._.

Estrogen_NN
receptors_NNS
are_VBP
found_VBN
on_IN
vascular_JJ
endothelial_JJ
and_CC
smooth_JJ
muscle_NN
cells_NNS
;_:
their_PRP$
expression_NN
is_VBZ
influenced_VBN
by_IN
exposure_NN
to_TO
the_DT
hormone_NN
._.

Estrogen_NN
receptors_NNS
influence_VBP
non-genomic_JJ
events_NNS
,_,
which_WDT
are_VBP
rapid_JJ
in_IN
onset_NN
and_CC
genomic_JJ
events_NNS
,_,
which_WDT
are_VBP
longer_RBR
acting_VBG
responses_NNS
._.

Estrogens_NNS
affect_VBP
vascular_JJ
tone_NN
indirectly_RB
by_IN
modulating_VBG
release_NN
of_IN
endothelium-derived_JJ
vasoactive_JJ
factors_NNS
and_CC
directly_RB
by_IN
modulating_VBG
intracellular_JJ
calcium_NN
in_IN
vascular_JJ
smooth_JJ
muscle_NN
cells_NNS
._.

Estrogens_NNS
indirectly_RB
affect_VBP
thrombotic_JJ
events_NNS
and_CC
inflammation_NN
by_IN
altering_VBG
platelet_NN
aggregation_NN
and_CC
leukocyte_NN
adherence_NN
and_CC
migration_NN
,_,
respectively_RB
._.

Estrogens_NNS
also_RB
influence_VBP
production_NN
of_IN
mitogens_NNS
which_WDT
,_,
when_WRB
released_VBN
at_IN
sites_NNS
of_IN
vascular_JJ
injury_NN
,_,
affect_VBP
vascular_JJ
remodeling_NN
._.

Although_IN
estrogens_NNS
initiate_VBP
vascular_JJ
responses_NNS
,_,
genomic_JJ
sex_NN
may_MD
influence_VB
and\/or_CC
limit_NN
expression_NN
of_IN
estrogen_NN
receptors_NNS
and_CC
therefore_RB
actions_NNS
of_IN
sex_NN
steroid_NN
hormones_NNS
throughout_IN
the_DT
vasculature_NN
._.

